Ozaki AF - Search Results

1

Prescribing patterns and factors associated with sodium-glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease.

Ozaki AF, Ko DT, Chong A, Fang J, Atzema CL, Austin PC, Stukel TA, Tu K, Udell JA, Naimark D, Booth GL, Jackevicius CA. Ozaki AF, et al. CMAJ Open. 2023 Jun 13;11(3):E494-E503. doi: 10.9778/cmajo.20220039. Print 2023 May-Jun. CMAJ Open. 2023. PMID: 37311594 Free PMC article.

2

Health Disparities in Pharmacy Practice Within the Community: Let's Brainstorm for Solutions.

Hurley-Kim K, Unonu J, Wisseh C, Cadiz C, Knox E, Ozaki AF, Chan A. Hurley-Kim K, et al. Among authors: ozaki af. Front Public Health. 2022 Apr 8;10:847696. doi: 10.3389/fpubh.2022.847696. eCollection 2022. Front Public Health. 2022. PMID: 35462836 Free PMC article.

3

A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases.

Takeda T, Sugimoto S, Matsumoto J, Iwata N, Nakamoto A, Ozaki AF, Hamano H, Ariyoshi N, Zamami Y. Takeda T, et al. Among authors: ozaki af. Int J Clin Pharm. 2024 Apr;46(2):536-541. doi: 10.1007/s11096-023-01687-6. Epub 2024 Jan 19. Int J Clin Pharm. 2024. PMID: 38240964

4

Cross-cultural Comparison of Pharmacy Students' Attitudes, Knowledge, Practice, and Barriers Regarding Evidence-based Medicine.

Ozaki AF, Nakagawa S, Jackevicius CA. Ozaki AF, et al. Am J Pharm Educ. 2019 Jun;83(5):6710. doi: 10.5688/ajpe6710. Am J Pharm Educ. 2019. PMID: 31333249 Free PMC article.

5

Population Impact of Generic Valsartan Recall.

Jackevicius CA, Krumholz HM, Chong A, Koh M, Ozaki AF, Austin PC, Udell JA, Ko DT. Jackevicius CA, et al. Among authors: ozaki af. Circulation. 2020 Feb 4;141(5):411-413. doi: 10.1161/CIRCULATIONAHA.119.044494. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707798 No abstract available.

6

Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Ozaki AF, et al. Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32148102

7

National Trends in the Use of Sacubitril/Valsartan.

Ozaki AF, Krumholz HM, Mody FV, Jackevicius CA. Ozaki AF, et al. J Card Fail. 2021 Aug;27(8):839-847. doi: 10.1016/j.cardfail.2021.05.015. J Card Fail. 2021. PMID: 34364661

8

Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction.

Ozaki AF, Krumholz HM, Mody FV, Tran TT, Le QT, Yokota M, Jackevicius CA. Ozaki AF, et al. Circ Cardiovasc Qual Outcomes. 2021 Sep;14(9):e007665. doi: 10.1161/CIRCOUTCOMES.120.007665. Epub 2021 Sep 1. Circ Cardiovasc Qual Outcomes. 2021. PMID: 34465124

9

Hospital-Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome.

Ozaki AF, Jackevicius CA, Chong A, Sud M, Fang J, Austin PC, Ko DT. Ozaki AF, et al. J Am Heart Assoc. 2022 Jul 5;11(13):e024835. doi: 10.1161/JAHA.121.024835. Epub 2022 Jun 29. J Am Heart Assoc. 2022. PMID: 35766263 Free PMC article.

10

Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes.

Moon J, Ozaki AF, Chong A, Sud M, Fang J, Austin PC, Ko DT, Jackevicius CA. Moon J, et al. Among authors: ozaki af. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5704. doi: 10.1002/pds.5704. Epub 2023 Sep 29. Pharmacoepidemiol Drug Saf. 2024. PMID: 37771242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters